ARID5B and prostate carcinoma: For example, ARID5B, has been associated with leukemia (Treviño et al., 2009), prostate cancer (Davalieva et al., 2015), gastric cancer (Lim et al., 2014), and endometrial carcinoma (Kandoth et al., 2013).